We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$7.47B
AUM Growth
+$318M
Cap. Flow
-$240M
Cap. Flow %
-3.22%
Top 10 Hldgs %
15.62%
Holding
988
New
245
Increased
155
Reduced
180
Closed
244

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$145M
2
BKNG icon
Booking.com
BKNG
+$116M
3
EA icon
Electronic Arts
EA
+$87.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$74.1M
5
MSFT icon
Microsoft
MSFT
+$66.5M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 31.02%
3 Industrials 9.63%
4 Financials 6.43%
5 Consumer Discretionary 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMO
226
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.01B
$9.15M 0.12%
+320,009
New +$9.22M
V icon
227
Visa
V
$688B
$9.07M 0.12%
43,663
+16,624
+61% +$3.35M
DG icon
228
Dollar General
DG
$28B
$9.05M 0.12%
36,748
-17,155
-32% -$4.24M
INFY icon
229
Infosys
INFY
$50.5B
$9.04M 0.12%
+502,171
New +$9.34M
BLUE
230
DELISTED
bluebird bio
BLUE
$8.93M 0.12%
64,535
+7,607
+13% +$1.07M
ULTA icon
231
Ulta Beauty
ULTA
$23.2B
$8.92M 0.12%
19,006
-26,905
-59% -$11.6M
MAXR
232
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$8.87M 0.12%
+171,515
New +$4.71M
ROST icon
233
Ross Stores
ROST
$81.2B
$8.84M 0.12%
76,191
-39,482
-34% -$4.03M
PMVP icon
234
PMV Pharmaceuticals
PMVP
$62.4M
$8.78M 0.12%
1,008,687
+109,380
+12% +$1.17M
CSCO icon
235
Cisco
CSCO
$479B
$8.69M 0.12%
+182,471
New +$8.31M
PYCR
236
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$8.51M 0.11%
347,831
+200,490
+136% +$5.55M
BHC icon
237
Bausch Health
BHC
$2.35B
$8.48M 0.11%
1,349,572
-1
-0% -$7
PCTY icon
238
Paylocity
PCTY
$8.18B
$8.42M 0.11%
+43,356
New +$9.31M
BLCO icon
239
Bausch + Lomb
BLCO
$5.99B
$8.38M 0.11%
+540,544
New +$8.12M
NYT icon
240
New York Times
NYT
$10.6B
$8.25M 0.11%
+254,304
New +$8.29M
AVEO
241
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$8.2M 0.11%
+548,191
New +$7.59M
TWOA
242
DELISTED
two
TWOA
$8.19M 0.11%
813,114
+200,000
+33% +$2M
LCAA
243
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$8.19M 0.11%
810,400
LRMR icon
244
Larimar Therapeutics
LRMR
$426M
$8.02M 0.11%
1,941,739
OKLO
245
Oklo
OKLO
$7.48B
$7.94M 0.11%
800,000
ACHC icon
246
Acadia Healthcare
ACHC
$3B
$7.83M 0.1%
95,089
-47,931
-34% -$3.95M
ROSS
247
DELISTED
Ross Acquisition Corp II
ROSS
$7.76M 0.1%
766,668
+66,668
+10% +$668K
APEN
248
DELISTED
Apollo Endosurgery, Inc.
APEN
$7.61M 0.1%
+762,800
New +$5.69M
IRBT
249
DELISTED
iRobot
IRBT
$7.6M 0.1%
158,000
-13,900
-8% -$735K
EHAB
250
DELISTED
Enhabit
EHAB
$7.59M 0.1%
576,814
+307,176
+114% +$4.1M

Similar funds

Woodline Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Woodline Partners held 988 positions worth $7.47B, up 4.4% from $7.16B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $240M in Q4 2022, closing 244 positions and reducing 180 holdings. Its most notable exit was Amazon, an estimated $77.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in Booking.com worth $123M.

  • Woodline Partners's largest Q4 2022 buy was Booking.com: 1,526,600 shares worth $123M.
  • Woodline Partners added most to TE Connectivity in Q4 2022, an estimated $145M increase.
  • Woodline Partners's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $169M.
  • Woodline Partners fully exited Amazon in Q4 2022, selling an estimated $77.2M.
  • Woodline Partners's ten largest holdings make up 16% of its $7.47B portfolio in Q4 2022.
  • Woodline Partners opened 245 new positions and closed 244 in Q4 2022.
  • Woodline Partners's portfolio value rose 4.4% quarter-over-quarter to $7.47B.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.